CD64+ Binding: Description, Relevance, and Potential Clinical Implications

Join Gabriella McCarty, NP-C and Andrea Banty, NP, as they explore the role of CD64-positive binding and IL-23 inhibition in IBD treatment. Discover how these mechanisms impact Crohn’s disease and ulcerative colitis management, offering insights into emerging therapies and clinical applications. Subscribe for more GI and hepatology updates!